342 related articles for article (PubMed ID: 24477081)
21. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
[TBL] [Abstract][Full Text] [Related]
22. Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion.
Nandyala SV; Marquez-Lara A; Fineberg SJ; Pelton M; Singh K
Spine (Phila Pa 1976); 2014 Feb; 39(3):185-91. PubMed ID: 24253788
[TBL] [Abstract][Full Text] [Related]
23. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.
Carragee EJ; Mitsunaga KA; Hurwitz EL; Scuderi GJ
Spine J; 2011 Jun; 11(6):511-6. PubMed ID: 21612985
[TBL] [Abstract][Full Text] [Related]
24. Bone morphogenetic protein (RhBMP-2) as a substitute for iliac crest bone graft in multilevel adult spinal deformity surgery: minimum two-year evaluation of fusion.
Mulconrey DS; Bridwell KH; Flynn J; Cronen GA; Rose PS
Spine (Phila Pa 1976); 2008 Sep; 33(20):2153-9. PubMed ID: 18725869
[TBL] [Abstract][Full Text] [Related]
25. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
Hiremath GK; Steinmetz MP; Krishnaney AA
Spine (Phila Pa 1976); 2009 Apr; 34(9):885-9. PubMed ID: 19531997
[TBL] [Abstract][Full Text] [Related]
26. Safety, efficacy, and dosing of recombinant human bone morphogenetic protein-2 for posterior cervical and cervicothoracic instrumented fusion with a minimum 2-year follow-up.
Hamilton DK; Smith JS; Reames DL; Williams BJ; Chernavvsky DR; Shaffrey CI
Neurosurgery; 2011 Jul; 69(1):103-11; discussion 111. PubMed ID: 21368688
[TBL] [Abstract][Full Text] [Related]
27. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
Lee DD; Kim JY
J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
[TBL] [Abstract][Full Text] [Related]
28. Prospective multicenter assessment of perioperative and minimum 2-year postoperative complication rates associated with adult spinal deformity surgery.
Smith JS; Klineberg E; Lafage V; Shaffrey CI; Schwab F; Lafage R; Hostin R; Mundis GM; Errico TJ; Kim HJ; Protopsaltis TS; Hamilton DK; Scheer JK; Soroceanu A; Kelly MP; Line B; Gupta M; Deviren V; Hart R; Burton DC; Bess S; Ames CP;
J Neurosurg Spine; 2016 Jul; 25(1):1-14. PubMed ID: 26918574
[TBL] [Abstract][Full Text] [Related]
29. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.
Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984
[TBL] [Abstract][Full Text] [Related]
30. Complications with recombinant human bone morphogenic protein-2 in posterolateral spine fusion: a consecutive series of 1037 cases.
Glassman SD; Howard J; Dimar J; Sweet A; Wilson G; Carreon L
Spine (Phila Pa 1976); 2011 Oct; 36(22):1849-54. PubMed ID: 20838369
[TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of retrograde ejaculation using semen analysis, comparison with a standardized qualitative questionnaire, and investigating the impact of rhBMP-2.
Tepper G; Rabbani R; Yousefzadeh M; Prince D
Spine (Phila Pa 1976); 2013 May; 38(10):841-5. PubMed ID: 23403551
[TBL] [Abstract][Full Text] [Related]
32. Bone Morphogenetic Proteins in Spinal Surgery: What Is the Fusion Rate and Do They Cause Cancer?
Malham GM; Giles GG; Milne RL; Blecher CM; Brazenor GA
Spine (Phila Pa 1976); 2015 Nov; 40(22):1737-42. PubMed ID: 26730525
[TBL] [Abstract][Full Text] [Related]
33. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
Slosar PJ; Josey R; Reynolds J
Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
35. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
Hofstetter CP; Hofer AS; Levi AD
J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283
[TBL] [Abstract][Full Text] [Related]
36. Complications in Adult Patients with Down Syndrome Undergoing Cervical Spine Surgery Using Current Instrumentation Techniques and rhBMP-2: A Long-Term Follow-Up.
Siemionow K; Hansdorfer M; Janusz P; Mardjetko S
J Neurol Surg A Cent Eur Neurosurg; 2017 Mar; 78(2):113-123. PubMed ID: 27448197
[No Abstract] [Full Text] [Related]
37. Urological complications following use of recombinant human bone morphogenetic protein-2 in anterior lumbar interbody fusion: presented at the 2012 Joint Spine Section Meeting: clinical article.
Lubelski D; Abdullah KG; Nowacki AS; Alvin MD; Steinmetz MP; Chakka S; Li Y; Gajewski N; Benzel EC; Mroz TE
J Neurosurg Spine; 2013 Feb; 18(2):126-31. PubMed ID: 23231356
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
[TBL] [Abstract][Full Text] [Related]
39. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine.
Smucker JD; Rhee JM; Singh K; Yoon ST; Heller JG
Spine (Phila Pa 1976); 2006 Nov; 31(24):2813-9. PubMed ID: 17108835
[TBL] [Abstract][Full Text] [Related]
40. Does bone morphogenetic protein increase the incidence of perioperative complications in spinal fusion? A comparison of 55,862 cases of spinal fusion with and without bone morphogenetic protein.
Williams BJ; Smith JS; Fu KM; Hamilton DK; Polly DW; Ames CP; Berven SH; Perra JH; Knapp DR; McCarthy RE; Shaffrey CI;
Spine (Phila Pa 1976); 2011 Sep; 36(20):1685-91. PubMed ID: 21897187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
